Assignee
CHEMIMMUNE THERAPEUTICS LLC
RU·1 granted patent·1 pending application·0 citations·filing 2018–2019
Top patents by PatentIndex Score
2 records- 0140US2022362230A1Use of glutarimide derivative for overcoming steroid resistance and treating diseases associated with aberrant interferon gamma signalingCHEMIMMUNE THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 0236US11439631B2Use of a glutarimide derivative to treat diseases related to the aberrant activity of cytokines“CHEMIMMUNE THERAPEUTICS” LLC·Filed 2018·Granted Sep 13, 2022·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when CHEMIMMUNE THERAPEUTICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →